Immunologic effccts of pre-and postnatal polychlorinated biphenyl (PCB)/dioxin exposure in Dutch infants from birth to 18 mo of agc are explored. The total study group consisted of 207 healthy mother-infant pairs, of which 105 infants were breast-fed and 102 children were bottle-fed. Prenatal PCB exposure was estimated by the PCB sum (PCB congeners 118, 138, 153, and 180) in maternal blood and the total toxic equivalent (TEQ) level in human milk (17 dioxin and 8 dioxin-like PCB congeners). Postnatal PCBIdioxin exposure was calculated as a product of the total TEQ level in human milk multiplied by the weeks of breast-feeding. The number of periods with rhinitis, bronchitis, tonsillitis, and otitis during the first 18 mo of life was used as an estimate of the health status of the infants. Humoral immunity was measured at 18 mo of age by detecting antibody levels to mumps, measles, and rubella. White blood cell counts (monocytes, granulocytes, and Iymphocytcs) and immunologic marker analyses CD4 ' T-lymphocytes, CD8+ T-lymphocytes, activated T-lymphocytes (HLA-DR.'-CD3+), as well as T cell receptor (TcR) cyp'., TcRySt, CD4+CD45RA+ and CD4+CD45ROi' T-lymphocytes, B-lymphocytes (CDIYf andlor CD20t) and NK cells (CD16' and/or CD56+/CD3-) in cord blood and venous blood at 3 and 18 mo of age were assessed in a subgroup of 55 PrenataI and postnatal exposure to PCDD, PCDF, and PCB produce a wide spectrum of toxic effects in animals, including body weight loss, hepatotoxicity, teratogenicity, carcinogenicity, neurotoxicity, reproductive toxicity, alterations in the thy-
infants. There was no relationship between pre-and postnatal PCBIdioxin exposure and upper or lowcr respiratory tract symptoms or humoral antibody production. A higher prenatal PCB/ dioxin exposure was associated with an increase in the number of TcRySt T cells at birth and with an increase in the total number of T cells and the number of CD8+ (cytotoxic), TcRap+, and TcRySf T cells at 18 mo of age. A higher prenatal as well as postnatal PCB/dioxin exposure was associated with lower monocyte and granulocyte counts at 3 mo of age. In conclusion, our study suggests that background levels of PCBidioxin exposure influences the human fetal and neonatal immune system. ( roid hormone status (I), and immunotoxicity. Many animal studies have shown adverse effects of PCDD, P C D F (summarized as dioxins), and P C B on the immune system. The most consistent finding in these studies is thymic atrophy (2-5). In utero and lactational exposure is a more sensitive period for the immunotoxic effects than adult exposure, suggesting that during maturation the immune system is particularly sensitive to these compounds.
Most studies were conducted in mice in which the adult, as well as the fetus, is very sensitive to immunotoxic effects.
There is evidence that perinatal TCDD exposure produces an alteration in the normal thymocyte maturation process (5-10). In addition a direct effect on the fetal liver and neonatal bone marrow has been shown (2, 7, 8). TCDD and TCDF may also interfere with B cell maturation and with humoral antibody production (11) (12) (13) (14) . In addition an increased activity of NK cells has been found (15). A decrease in thymus weight and alterations in T cell differentiation, however, were also found in TCDD exposed rats (4, 16) and a reduction in thymocytes in the offspring of PCB exposed pregnant minks (17). Neubert et al. (18, 19) found changes in the number of B cell, NK cell, and T cell subpopulations in venous blood of marmosets treated with low doses of TCDD. In seals fed on PCDD-, PCDF-, and PCB-polluted herrings, lower NK and T cell activity was found. In addition there were higher levels of circulating polymorphonuclear granulocytes, which may suggest an increase in the occurrence of bacterial infections (20) .
Data regarding the potential toxic effects of PCDD, PCDF, and PCB on the immune system in human beings are scarce. In vitro studies of human venous blood and lymphocyte fractions incubated with low doses of TCDD demonstrated a decrease in B cells and C D~+ (helper) T cells and an increase in C D~+ (cytotoxic) T cells (21). The first indication that PCB and dioxins might be immunotoxic in vivo came from studies in accidentally exposed humans (22-29). In highly industrialized, densely populated Western European countries, like the Netherlands, dioxin levels in human milk samples can be especially high (10-100 pg TEQIg milk fat). Whether prenatal and postnatal exposure to these high background levels of PCDD, PCDF, and PCB can alter the immune system in human infants and whether the health of the infant is adversely affected by these pollutants is not known. In this report we explore the immunologic effects of environmental prenatal and postnatal background exposure to PCDD, PCDF, and PCB in infants from birth to 18 mo of age. This study is part of the Dutch PCBIDioxin Study, a larger prospective longitudinal study on possible adverse health effects of these pollutants on human infants.
METHODS

Subjects.
The total study group consisted of 207 healthy mother-infant pairs, recruited between June 1990 and February 1992, living in the Rotterdam area and was described in detail in a previous paper (30) . All mother-infant pairs were of the Caucasian race. Pregnancy and delivery had to be completed without overt signs of serious illness or complications. Only infants born at term (37 to 42 wk of gestation) without congenital anomalies or diseases were included. A hundred and five infants were breast-fed for at least 6 wk, 102 infants were exclusively bottle-fed with Almiron M2 from one batch (Nutricia N.V., The Netherlands). A description of the characteristics of the total study group is presented in Table 1 .
In a subgroup of infants, recruited between March 1991 and February 1992, white blood cell counts and immunologic marker analyses in cord and venous blood at 3 and 18 mo of age were done. Because fresh blood is needed for these measurements, only infants born on a weekday and living close to the hospital were included in this part of the study. A descrip- tion of the characteristics of the subgroup in comparison to the total group is presented in Table 1 . In 48 infants cord blood was analyzed. At 3 mo of age, in 1 of the original 48 children the venipuncture was not successful, and a randomly chosen child was added to the study group. At 18 mo of age fresh blood was available for analysis in 37 of the original 48 children, and 6 randomly chosen children were added. There were no significant differences betweerr the total study group and the subgroup.
Measures of PCB/dioxin exposure. A blood sample was taken from the mothers in the last month of pregnancy (36 to 40 wk) and analyzed by GC with electron capture detection for the measurement of four PCB congener levels (PCB 118, 138, 153, and 180). The four congener levels were added and summarized as the PCB-plasma-sum. One blood sample was missing for this analysis. In the second week after delivery, the breast-feeding mothers collccted a 24-h representative human milk sample with a vacuum pump (KAWECO, Babyluxus 2, Stuttgart, Germany). Seventeen individual dioxin congener and 24 PCB congener levels were measured. Congener specific analyses of PCDD, PCDF, and PCB were carried out using previously described methods (31) . The international toxic equivalence factor approach was used for PCDD and PCDF (32) and the WHO 1993 approach for PCB (33) . According to the TEQ concept, a toxic equivalent factor was assigned to the 17 dioxin and 8 dioxin-like (planar, mono-ortho and di-ortho) PCB congeners. By multiplying the concentration (pg/g milk fat) and the toxic equivalence factor value, a TEQ value of each congener was calculated (pg TEQ/g milk fat). The TEQsum of the 17 dioxin, 3 planar PCB (77, 126, 169), 3 monoortho PCB (105, 118, 156), and 2 di-ortho PCB (170, 180) congeners were summarized as the total TEQ level. Of the 105 human milk samples, 80 could be measured with sufficient accuracy for the total TEQ level. The other analytical measurements were inaccurate due to interferences in the chromatograms, or due to too small volumes of human milk samples and therefore excluded from further analyses. As a measure of prenatal exposure, the PCB-plasma-sum of all individual mother-infant pairs was used. For the breast-fed infants the total TEQ level in human milk was separately studied as an estimate of the prenatal exposure. Postnatal PCBIdioxin exposure was calculated as a product of the total TEQ level in human milk, multiplied by weeks of breast-feeding.
Measures of immunologic effects. All parents were asked to complete a health questionnaire regarding their infant. The number of periods with rhinitis, bronchitis, tonsillitis, and otitis during the first 18 mo of life was counted and used as an estimate of the health status of the infants.
Vaccinations against mumps, measles, and rubella were given to 205 of the 207 children at approximately 14 mo of age as part of the National Immunization Program. The vaccines were given at the local municipal health service. Humoral antibody production was measured at 18 mo of age by detecting antibody levels to mumps, measles, and rubella in plasma with an ELISA (34) .
Monocyte, granulocyte, and lymphocyte counts were determined by whole blood fluorescence-activated cell sorter analysis combined with the determination of the white blood cell count by a cell counter (35) . Using several MAb, absolute numbers of the following lymphocyte (sub)populations were determined: CD4' T-lymphocytes (CD4+ C D~+ ) , CD8+ Tlymphocytes (CD8 '~CD3-'-), activated T-lymphocytes (HLA-DR+CD3+), as well as TcRcrp+, TcRyG+, C D~+ C D~~R A + and CD4+CD45ROt T-lymphocytes, B-lymphocytes (CD19+ and/or ~D 2 0 + ) , and NK cells (CD16+ and/or CD56+/CD3-). Data analysis. Data analysis was performed using the statistical software package SPSS win 6.01. The relationship between immunologic parameters and PCBIdioxin exposure was studied in univariate analyses (t test, 2 test, and Spearman correlation coefficient). In a first analysis prenatal (PCBplasma-sum and total TEQ) and postnatal (total TEQ multiplied by weeks of breast-feeding) PCB-dioxin exposure were studied in relation to the immunologic parameters. When the PCB-plasma-sum was significantly correlated ( p 5 0.05,) with the outcome variable, analyses of the separate PCB congener levels 118, 138, 153, and 180 in maternal plasma were done. When the total TEQ was significantly correlated with the outcome variable, analyses of the dioxin and dioxin-like (planar, mono-ortho, and di-ortho) PCB congeners in human milk were done. Potential confounding variables at birth (birth weight, gestational age, sex, smoking and alcohol use during pregnancy, maternal education, and paternal occupation) and at 3 and 18 mo of age (sex, nutritional status, duration of breastfeeding, maternal education, and paternal occupation) were selected, according to clinical and immunologic knowledge. Potential confounding variables were analyzed when the PCB/ dioxin exposure was significantly correlated with the outcome variable.
The study protocol had been approved by the medical ethical committee of the University Hospital Rotterdam/Sophia Children's Hospital. Informed consent had been given by the parents.
RESULTS
The mean PCB-plasma-sum in the total group was 2.25 pg/L (SD 0.98, n = 206) and the mean total TEQ level was 66.59 pg/g fat (SD 24.35, n = 80). The mean PCB-plasma-sum in the subgroup was 2.10 pg/L (SD 0.87, n = 55) and the mean total TEQ was 64.20 pg/g fat (SD 19.08, n = 19). There were no significant differences in the mean PCB-plasma-sum or total TEQ level between the total group and the subgroup.
There were no significant correlations between the number of periods with rhinitis, bronchitis, tonsillitis, and otitis during the first 18 mo of life and prenatal (PCB-plasma-sum and total TEQ level) and postnatal (total TEQ level multiplied by the number of breast-feeding weeks) PCBldioxin exposure. There were also no significant correlations between the specific antibody levels to mumps, measles, and rubella at 18 mo of age and pre-and postnatal PCB/dioxin exposure.
The results of the white blood cell counts and the immunologic marker analyses in cord blood and venous blood at 3 and 18 mo of age are presented in Table 2 . The results are all within the normal ranges in age-matched children. Correlations between the different leukocyte (sub)populations and pre-and postnatal PCB/dioxin exposure are presented in Table 3 .
At birth a higher total TEQ level was correlated with an increase in T C R~G + T cells ( p = 0.03). Correlation coefficients with the dioxin, planar, mono-ortho, and di-ortho PCB congeners only reached statistical significance for the dioxin TEQ level (Table 4 , p = 0.01). There were no significant correlations between the number of T C R~G + T cells and the potential confounders.
At 3 mo of age a higher total TEQ level was significantly correlated with a decrease in the number of monocytes ( p = 0.003) and granulocytes ( p = 0.04). A higher postnatal exposure was significantly correlated with a decrease in the total number of monocytes ( p = 0.03), granulocytes ( p = 0.01), and B-cells ( p = 0.05). The monocyte count was significantly correlated with the dioxin TEQ level ( p = 0.01), the monoortho (p = 0.002), and di-ortho ( p = 0.03) PCB TEQ level. The granulocyte count was significantly correlated only with the total TEQ level; correlation coefficients with the dioxin, planar, mono-ortho, and di-ortho PCB congener levels did not reach statistical significance (Table 4) . There was no significant correlation between the monocyte and granulocyte counts and the potential confounders. The number of ~~1 9 1 2 0~ cells was significantly correlated with the duration of breast-feeding (rs = 0.64, p = 0.003).
At 18 mo of age higher total TEQ and PCB-plasma-sum levels were significantly correlated with an increase in the number of CD8+ T cells (PCB-plasma-sum, p = 0.01, total TEQ, p = 0.002). In maternal plasma PCB 118 (r, = 0.33, p = 0.03), PCB 138 (r, = 0.32, p = 0.04), PCB 153 (rs = 0.37, ( n = 1 9 ) ( n = 4 8 ) ( n = 1 9 ) ( n = 1 9 ) ( n = 4 3 ) ( n = 1 2 ) ( n = (Table   4 ). In addition a higher dioxin TEQ level was also significantly correlated with more C D~+ (rs = 0.61, p = 0.04) and T~R~G + (r, = 0.70, p = 0.01) T cells. There were no significant correlations of the T cell markers at 18 mo of age with postnatal PCBIdioxin exposure nor with the potential confounders.
Comparing the number of periods with respiratory tract infections and the leukocyte (sub)population at 18 mo of age, there was a significant relationship only between the number of periods with bronchitis and the C D~+ C D~~R A + T-lymphocytes (r, = 0.33, p = 0.04). Antibody levels to mumps were correlated with the total number of lyniphocytes (rs = 0.32, 
DISCUSSION
In this study two different effects of PCBidioxin background exposure on the developing immune system of human infants were found. Prenatal PCBIdioxin exposure was associated with changes in T cell subpopulations in the blood. These changes were mainly seen at 18 mo of age. At that age a higher prenatal PCBIdioxin exposure was associated with an increase in the total number of T cells as well as with an increase in the number of C D~+ (cytotoxic), TcRcr/3+ and T C R~G + T cells.
These prenatal effects of PCBIdioxin exposure on changes in T cell subpopulations at a later age are consistent with findings in other human studies. In children born to mothers living in a TCDD-contaminated environment in Time Beach, MO, during and after pregnancy, a decrease in C D~+ (helper) T cells and an increase of C D~+ (cvtotoxic) T cells has even been dem-\ 2 onstrated at 9 to 14 y of age (28) . In one preliminary report from Northern Quebec, Inuit infants whose mothers have elevated levels of PCB and dioxins in their breast milk, the C D~+ (helper):C~8+ (cytotoxic) T cell ratio was decreased at 6 and 12 mo of age, but not at 3 mo of age (29) . Our results are also in agreement with animal studies, where perinatal TCDD exposure produces an alteration in the normal thymocyte maturational process (5, 6). Moreover, in vitro studies of human venous blood and lymphocyte fractions incubated with TCDD demonstrated a decrease in CD4+ (helper) T cells and an increase in CD8+ (cytotoxic) T cells (21). In contrast to the above studies, we did not find a decrease in C D~+ (helper) T cells. All of these studies were, however, conducted in vitro or in higly exposed infants, whereas our study was conducted in background PCBIdioxin-exposed infants. A higher prenatal as well as postnatal PCBIdioxin exposure was associated with lower monocyte and granulocyte counts only at 3 mo of age. The effects on the lymphocyte count fell short of statistical significance. Our findings are in agreement with animal studies where a direct effect on the fetal liver and neonatal bone marrow was found after perinatal dioxin exposure (2, 7, 8). In Taiwan, in the Yucheng incident, changes in the monocyte maturational process were found in PCBpoisoned patients (23). Our results also agree with a previous study in Dutch infants where a negative correlation between dioxin concentrations in breast milk and the number of granulocytes was found at 1 wk of age (36) . Correlation coefficients of the monocyte and lymphocyte counts with prenatal PCB/ dioxin exposure were higher than with postnatal exposure. Correlation coefficients of the granulocyte count with prenatal PCBIdioxin exposure were lower than with postnatal exposure. Unfortunately due to the nonparametric distribution of the white blood cell counts and the small numbers of cases left, multivariate analysis was impossible.
A higher postnatal PCB/dioxin exposure was associated with a decrease in the number of C~1 9 1 2 0~ B cells. In the children, born to mothers living in TCDD-contaminated Time Beach, MO, a decrease in B cells has also been demonstrated (28) . Moreover, in vitro studies of human peripheral blood lymphocyte fractions incubated with TCDD showed a decrease of B cells (21). In our study group, however, the correlation coefficient of the number of B cells with the duration of breast feeding was higher than with postnatal PCBIdioxin exposure. We therefore presume that the decrease in B cells was mainly an effect of breast feeding. Further studies on the effect of breast feeding on the immune status of the infant are needed.
In our study there was no evidence of increased upper or lower respiratory tract symptoms or altered humoral antibody production in relation to PCBIdioxin exposure. Although there were differences in the leukocyte (sub)population between high and low PCBIdioxin-exposed infants, all values were within the normal range. Moreover, subtle changes in the number of blood leukocytes do not simply mirror alterations in the cell composition of lymphoid and nonlymphoid organs, nor do they simply reflect functional defects. In children born to accidentally highly exposed women, in the Yucheng incident, an increased incidence of respiratory symptoms was found (26) . The Inuit infants, whose mothers had elevated levels of PCB and dioxins in their breast milk, experienced more episodes of acute otitis media at 3 to 6 mo of age (29) . In a prospective longitudinal study of background PCB exposure in the United States, however, there was no adverse effect on the frequency of physician visits for various illnesses (37) . The magnitude of REFERENCES the above described changes in the immune status of background-exposed infants associated with prenatal PCB/dioxin 
